Revolution Medicines, Inc. (NASDAQ:RVMD) has 378 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 19,532,992 | 7,229,490 | 58.76% | $1,899,074,252.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 13,604,796 | -978,000 | -6.71% | $1,323,066,411.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 11,212,706 | 2,286,050 | 25.61% | $1,090,435,565.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 9,555,357 | 100,000 | 1.06% | $929,258,468.00 |
| FMR LLC | 31 Mar, 2026 | 8,464,314 | -123,667 | -1.44% | $823,154,497.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 8,362,284 | 8,362,284 | 0.00% | $813,232,119.00 |
| Nextech Invest, Ltd. | 31 Mar, 2026 | 7,601,087 | 0 | 0.00% | $739,205,711.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 7,502,623 | 7,502,623 | 0.00% | $729,630,087.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 6,655,703 | 11,300 | 0.17% | $647,267,117.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 6,027,819 | -959,820 | -13.74% | $586,205,399.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 5,475,611 | 3,270,056 | 148.26% | $532,503,170.00 |
| State Street Corp | 31 Mar, 2026 | 4,402,662 | 293,372 | 7.14% | $428,158,880.00 |
| UBS Group AG | 31 Mar, 2026 | 4,386,791 | 1,298,854 | 42.06% | $426,615,425.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 3,338,142 | 176,179 | 5.57% | $323,930,219.00 |
| Alphabet Inc. | 31 Mar, 2026 | 3,292,525 | -52,577 | -1.57% | $320,198,056.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 3,232,213 | 3,232,213 | 0.00% | $314,333.00 |
| BVF INC/IL | 31 Mar, 2026 | 2,856,782 | -500,000 | -14.90% | $277,822,050.00 |
| Casdin Capital, LLC | 31 Mar, 2026 | 2,577,333 | 0 | 0.00% | $250,645,634.00 |
| Woodline Partners LP | 31 Mar, 2026 | 2,506,570 | 5,675 | 0.23% | $243,763,933.00 |
| Holocene Advisors, LP | 31 Mar, 2026 | 2,468,644 | 560,696 | 29.39% | $240,075,629.00 |